期刊文献+

儿童系统性红斑狼疮神经精神症状的研究(一) 被引量:5

Neuropsychiatric symptoms in Chinese children with systemic lupus erythematosus
原文传递
导出
摘要 目的通过分析儿童系统性红斑狼疮(SLE)神经精神症状的发病情况、临床及实验室表现、治疗等,探讨中国儿童神经精神性狼疮(NPSLE)的发病特点。方法回顾性研究1990-2006年诊断为SLE的62例中国儿童SLE患者。收集神经精神症状发病时的性别、年龄、病程、临床表现、实验室检查、影像学检查、治疗等资料,并与其他研究结果相对比。结果19例(31%)患者被诊断为NPSLE,共发生症状21次;最常见的神经精神症状是认知障碍(48%)、癫痫(43%)和头痛(29%)。单光子发射计算机断层成像(SPECT)的表现异常率达80%。86%的患者接受了甲泼尼龙治疗;大部分(74%)患者无神经精神系统后遗症。结论中国儿童SLE的神经精神症状是常见的,其发病特点与其他种族的报道有所不同;SPECT与MR是诊断NPSLE较敏感的辅助检查;儿童NPSLE的预后良好。 Objective To define the clinical characteristics of NPSLE in Chinese children by analyzing their demographic data, clinical manifestations, laboratory parameters and treatment. Methods Sixty- two children with SLE who were diagnosed between 1990 and 2006 were retrospectively reviewed. The demographic data, clinical manifestations, laboratory parameters, imaging and treatment were analyzed. The syndromes were compared with those reported in other studies. Results Nineteen (31%) SLE patients with 21 NP events were identified. The most common NP manifestations were cognitive dysfunction (48%), seizure disorder (43%) and headache (29%). The abnormality percentage of SPECT was 80%. 86% patients received MP pulses therapy. Most (74%) patients recovered without long-term neurological complications. Conclusi NP symptoms are common in Chinese children with SLE, however,the prese-ntations are different from that reported in other studies. SPECT and MR are sensitive tests for NPSLE. The prognosis of NPSLE in our series is favorable.
出处 《中华风湿病学杂志》 CAS CSCD 2008年第12期829-832,共4页 Chinese Journal of Rheumatology
关键词 红斑狼疮 系统性 狼疮血管炎 中枢神经系统 儿童 Lupus erythematosus,systemic Lupus vasculitis, central nervous system Child
  • 引文网络
  • 相关文献

参考文献20

  • 1Al-Mekaimi A, Malaviya AN, Serebour F, et al. Serological characteristics of systemic lupus erythematosus from a hospitalbased rheumatology clinic in Kuwait. Lupus, 1997, 6: 668-674.
  • 2Emori A, Matsushima E, Aihara O, et al. Cognitive dysfunction in systemic lupus erythematosus. Psychiatry Clin Neurosci, 2005, 59: 584-589.
  • 3Ainiala H, Loukkola J, Peltola J, et al. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology, 2001, 57: 496-500.
  • 4Sibbitt WL Jr, Brandt JR, Johnson CR, et al. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol, 2002, 29: 1536-1542.
  • 5Yancey CL, Doughty RA, Athreya BH. Central nervous system involvement in childhood systemic lupus erythematosus. Arthritis Rheum, 1981, 24: 1389-1395.
  • 6ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum, 1999, 42: 599-608.
  • 7Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 1982, 25: 1271-1277.
  • 8Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI: a disease activity index for lupus patients: the Committee on Prognosis Studies in SLE. Arthritis Rheum, 1992, 35: 630-640.
  • 9Steinlin MI, Blaser SI, Gilday DL, et al. Neurologic manifestations of pediatric systemic lupus erythematosus. Pediatr Neurol, 1995, 13: !91-197.
  • 10Alsaeid K, Kamal H, Haider MZ, et al. Systemic lupus erythematosus in Kuwaiti children: organ system involvement and serological findings. Lupus, 2004, 13: 613-617.

同被引文献44

  • 1Harel L, Sandborg C, Lee T, et al. Neuropsychiatric manifestations in pediatric systemic lupus erythematosus and association with antiphospholipid antibodies. J Rheumatol, 2006, 33: 1873- 1877.
  • 2Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 1982, 25: 1271-1277.
  • 3Feinglass EJ, Arnett FC, Dorseh CA, et al. Neuropsychiatric mani-festations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine (Baltimore), 1976, 55: 323-339.
  • 4Karassa FB, Ioannidis JP, Touloumi G, et al. Risk factors for central nervous system involvement in systemic lupus erythematosus. Q J Med, 2000, 93: 169-174.
  • 5Mok CC, Lau CS, Wong RW. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus. J Rheumatol, 2001, 28: 766-771.
  • 6Grigor R, Edmonds J, Lewkonia R, et al. Systemic lupus erythematosus: a prospective analysis. Ann Rheum Dis, 1978, 37: 121- 128.
  • 7Shimojima Y, Matsuda M, Gono T, et al. Relationship between clinical factors and neuropsychiatric manifestations in systemic lupus erythematosus. Clin Rheumatol, 2005, 24: 469-475.
  • 8Winn DM, Wolfe JF, Lindberg DA, et al. Identification of a clinical subset of systemic lupus erytbematosus by antibodies to the Sm antigen. Arthritis Rheum, 1979, 22: 1334-1337.
  • 9Winfield JB, Brunner CM, Koffler D. Serologic studies in patients with systemic lupus erythematosus and central nervous system dysfunction. Arthritis Rheum, 1978, 21: 289-294.
  • 10Mok CC, Mak A, Chu WP, et al. Long-term survival of southern Chinese patients with systemic lupus erythematosus: a prospective study of all age-groups. Medicine (Baltimore), 2005, 84: 218- 224.

引证文献5

二级引证文献7

;
使用帮助 返回顶部